329. Aniridia Disease details / Clinical trials / Drug dev / DR info /

Clinical trials : 3 / Drugs : 2 - (DrugBank : 2) / Drug target gene : 0 - Drug target pathway : 0

Drugs and their primary sponsors and trial info

Ataluren
   PTC Therapeutics
      2018   Phase 2   NCT04117880   -
      2016   Phase 2   NCT02647359   Canada;United States;
Mitomycin
   Department of Ophthalmology, Keio University School of Medicine
      2013   -   JPRN-UMIN000002948   Japan;